Suchergebnisse - "Shi, Yuankai"

PubPharm (531)

1

Efficacy and safety of utidelone for the treatment of patients with locally advanced or metastatic non-small-cell lung cancer who have failed standard second-line treatment : A phase 2 clinical trial (BG01-1801)

enthalten in: Cancer pathogenesis and therapy | 2024

von Shi, Y. | Chen, G. | Zhao, Y. | +2

2

Deciphering the Prognostic Significance of MYD88 and CD79B Mutations in Diffuse Large B-Cell Lymphoma : Insights into Treatment Outcomes

enthalten in: Targeted oncology | 2024

von Xie, Z. | Qin, Y. | Chen, X. | +9

3

Single-cell and spatial analyses revealed the co-location of cancer stem cells and SPP1+ macrophage in hypoxic region that determines the poor prognosis in hepatocellular carcinoma

enthalten in: NPJ precision oncology | 2024

von Fan, G. | Xie, T. | Li, L. | +3

4

High-throughput antigen microarray identifies longitudinal prognostic autoantibody for chemoimmunotherapy in advanced non-small cell lung cancer

enthalten in: Molecular & cellular proteomics : MCP | 2024

von Dai, L. | Tan, Q. | Li, L. | +13

5

Identification of novel prognostic autoantibodies in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone via a high-throughput antigen microarray

enthalten in: Cancer | 2024

von Dai, L. | Chen, H. | Tan, Q. | +14

6

Longitudinal plasma proteomic profiling of EML4-ALK positive lung cancer receiving ALK-TKIs therapy

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2024

von Wang, S. | Hao, X. | Dai, L. | +12

7

Genetic landscape and prognostic value of IRF4 alterations in Diffuse large B-cell lymphoma patients

enthalten in: ResearchSquare.com | 2024

von Qin, Y. | Chen, X. | Xie, Z. | +9

8

Sunvozertinib for patients in China with platinum-pretreated locally advanced or metastatic non-small-cell lung cancer and EGFR exon 20 insertion mutation (WU-KONG6) : single-arm, open-label, multicentre, phase 2 trial

enthalten in: The Lancet. Respiratory medicine | 2024

von Wang, M. | Fan, Y. | Sun, M. | +37

9

Longitudinal plasma proteomic analysis identifies biomarkers and combinational targets for anti-PD1-resistant cancer patients

enthalten in: Cancer immunology, immunotherapy : CII | 2024

von Tan, Q. | Gao, R. | Zhang, X. | +12

10

Longitudinal plasma proteomic analysis identifies biomarkers and combinational targets for anti-PD1-resistant cancer patients

enthalten in: Cancer immunology immunotherapy | 2024

von Tan, Q. | Gao, R. | Zhang, X. | +12

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[54]